Mengxia Li

5.2k total citations
191 papers, 3.4k citations indexed

About

Mengxia Li is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mengxia Li has authored 191 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 42 papers in Oncology and 38 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mengxia Li's work include RNA modifications and cancer (22 papers), DNA Repair Mechanisms (19 papers) and Lung Cancer Treatments and Mutations (14 papers). Mengxia Li is often cited by papers focused on RNA modifications and cancer (22 papers), DNA Repair Mechanisms (19 papers) and Lung Cancer Treatments and Mutations (14 papers). Mengxia Li collaborates with scholars based in China, United States and Germany. Mengxia Li's co-authors include David M. Wilson, Dong Wang, Nan Dai, Henning Neubauer, Yi Qing, Zhaoyang Zhong, Debing Xiang, Shiheng Zhang, Weihua Zhu and Yan Cao and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Mengxia Li

177 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengxia Li China 31 1.7k 516 449 374 359 191 3.4k
Chia‐Jung Li Taiwan 32 1.6k 0.9× 326 0.6× 646 1.4× 390 1.0× 402 1.1× 130 4.0k
Junling Liu China 35 1.6k 0.9× 477 0.9× 446 1.0× 484 1.3× 423 1.2× 181 4.1k
Mohammed Al‐Qahtani Saudi Arabia 31 1.3k 0.8× 522 1.0× 551 1.2× 235 0.6× 248 0.7× 150 3.2k
Zhichao Chen China 29 1.3k 0.8× 510 1.0× 679 1.5× 181 0.5× 203 0.6× 158 3.0k
Zhong Chen China 31 1.4k 0.8× 362 0.7× 591 1.3× 162 0.4× 348 1.0× 169 3.0k
Lirong Zhang China 36 2.1k 1.3× 628 1.2× 882 2.0× 361 1.0× 239 0.7× 202 4.3k
Sheridan M. Hoy New Zealand 34 1.9k 1.1× 771 1.5× 243 0.5× 224 0.6× 459 1.3× 129 4.5k
Hyun‐Ah Kim South Korea 32 1.5k 0.9× 868 1.7× 847 1.9× 233 0.6× 362 1.0× 228 4.1k
Huihui Zhang China 27 1.3k 0.8× 555 1.1× 441 1.0× 165 0.4× 268 0.7× 147 2.6k
Min Zhang China 32 1.5k 0.9× 578 1.1× 579 1.3× 386 1.0× 261 0.7× 209 4.1k

Countries citing papers authored by Mengxia Li

Since Specialization
Citations

This map shows the geographic impact of Mengxia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxia Li more than expected).

Fields of papers citing papers by Mengxia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengxia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxia Li. The network helps show where Mengxia Li may publish in the future.

Co-authorship network of co-authors of Mengxia Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mengxia Li. A scholar is included among the top collaborators of Mengxia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengxia Li. Mengxia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Wenli, et al.. (2025). Base excision repair in human cancer: Emerging diagnostic and therapeutic target. DNA repair. 152. 103879–103879. 1 indexed citations
2.
Li, C., Lin Cao, Yuxin Yang, et al.. (2025). Apurinic/apyrimidinic endonuclease 1 (APE1) prevents alopecia by promoting regeneration of hair follicles. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1872(5). 119951–119951.
3.
Jing, Xinming, et al.. (2024). The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma. Frontiers in Bioscience-Landmark. 29(4). 158–158. 2 indexed citations
4.
He, Jialiu, Mengxia Li, Zheng Zhu, et al.. (2024). Association between birth weight and chronic obstructive pulmonary disease in the UK Biobank: a prospective cohort study. BMJ Open Respiratory Research. 11(1). e002366–e002366. 1 indexed citations
5.
Song, Yang, et al.. (2023). Inhibition of IDH3α Enhanced the Efficacy of Chemoimmunotherapy by Regulating Acidic Tumor Microenvironments. Cancers. 15(6). 1802–1802. 3 indexed citations
6.
7.
Zhang, Qin, Han Gao, Yang Chen, et al.. (2023). APE1 promotes non-homologous end joining by initiating DNA double-strand break formation and decreasing ubiquitination of artemis following oxidative genotoxic stress. Journal of Translational Medicine. 21(1). 183–183. 7 indexed citations
8.
Chen, Jinlong, et al.. (2023). Assessing the Spatiotemporal Dynamics of Vegetation Coverage in Urban Built-Up Areas. Land. 12(1). 235–235. 9 indexed citations
9.
Li, Junjie, Yifei Yin, Mengxia Li, et al.. (2023). RUNX1 Methylation as a Cancer Biomarker in Differentiating Papillary Thyroid Cancer from Benign Thyroid Nodules. Epigenomics. 15(23). 1257–1272. 2 indexed citations
10.
Antoniali, Giulia, Emiliano Dalla, Xiaolong Zhao, et al.. (2022). APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b. Cellular and Molecular Life Sciences. 79(8). 446–446. 17 indexed citations
11.
Luo, Hao, Gaolei Liu, Dan Jian, et al.. (2022). Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade. Journal of Immunology Research. 2022. 1–21. 1 indexed citations
12.
Zhang, Qin, Yanli Xiong, He Xiao, et al.. (2022). A subset of VEGFR‐TKIs activates AMPK in LKB1‐mutant lung cancer. Cancer Science. 114(4). 1651–1662. 5 indexed citations
13.
Zhang, Liang, Mengxia Li, Bo Deng, et al.. (2019). <p>HLA-DQB1 expression on tumor cells is a novel favorable prognostic factor for relapse in early-stage lung adenocarcinoma</p>. Cancer Management and Research. Volume 11. 2605–2616. 16 indexed citations
14.
Wei, Liang, et al.. (2019). <p>MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression</p>. OncoTargets and Therapy. Volume 12. 7203–7214. 13 indexed citations
15.
Li, Mengxia, Xiaoxiao Liu, & Xianluo Hu. (2018). Fabrication of Core–Sheath NiCoP@FePx Nanoarrays for Efficient Electrocatalytic Hydrogen Evolution. ACS Sustainable Chemistry & Engineering. 6(7). 8847–8855. 30 indexed citations
16.
Li, Mengxia, Xiao Yang, Nan Dai, et al.. (2018). APE1 deficiency promotes cellular senescence and premature aging features. Nucleic Acids Research. 46(11). 5664–5677. 54 indexed citations
17.
Liu, Xiaoxiao, Lei Zhang, Mengxia Li, & Xianluo Hu. (2018). Tandem MoP nanocrystals with rich grain boundaries for efficient electrocatalytic hydrogen evolution. Chemical Communications. 54(20). 2502–2505. 31 indexed citations
18.
Zhang, Liang, Liwei Zhou, Mengxia Li, et al.. (2014). Induction of Apoptosis in Human Multiple Myeloma Cell Lines by Ebselen via Enhancing the Endogenous Reactive Oxygen Species Production. BioMed Research International. 2014. 1–10. 42 indexed citations
19.
Li, Mengxia. (2010). Establishment and indentification of mice model of radtion-induced lung injury. 1 indexed citations
20.
Zhang, Qinhong, et al.. (2009). Expression of DNA repair gene apurinic/apyrimidinic endonuclease 1 and its correlation with the expression of mutant p53 in hepatocellular carcinoma. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 8(6). 453–456. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chia‐Jung Li Breakdown of academic impact, for papers by Junling Liu Breakdown of academic impact, for papers by Mohammed Al‐Qahtani Breakdown of academic impact, for papers by Zhichao Chen Breakdown of academic impact, for papers by Zhong Chen Breakdown of academic impact, for papers by Lirong Zhang Breakdown of academic impact, for papers by Sheridan M. Hoy Breakdown of academic impact, for papers by Hyun‐Ah Kim Breakdown of academic impact, for papers by Huihui Zhang Breakdown of academic impact, for papers by Min Zhang
Rankless by CCL
2026